STAT July 5, 2024
Ed Silverman

Four large drugmakers — Novartis, Pfizer, Novo Nordisk, and Otsuka Pharmaceutical — were scolded by a U.K. industry trade group for violating a voluntary code that is designed to bolster marketing practices. In each case, the companies were chastised for discrediting — and reducing confidence in — the industry, while Novo Nordisk was singled out for a public reprimand.

The most serious breach involved Novo Nordisk, which voluntarily admitted its failure to disclose approximately $10 million that was provided to more than...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Pharma, Pharma / Biotech
In sustained rare disease push, Recordati lays out $825M upfront to acquire Sanofi's CAD drug Enjaymo
Pharma Pulse 10/3/24: Data Collection Complexities, 8 Things You May Not Know About Breast Cancer & more
New Techniques Make RNA Accessible to Study Variants of Uncertain Significance
Comprehensive strategies for prescription drug cost management
Gilead strikes deal to expand HIV drug access in 120 countries

Share This Article